Aiming for the global market, PYFA acquires a pharmaceutical company in Australia
Jakarta, December 22, 2023 – Pyridam Farma, through its subsidiary established in Australia, PYFA Australia Pty Ltd, plans to acquire Probiotec Limited by signing a Scheme Implementation Deed (SID) on December 21, 2023, which is a binding conditional agreement in connection with the plan of Pyridam Farma’s subsidiary to acquire all issued shares of Probiotec Limited.
Probiotec Limited is one of the largest Australian pharmaceutical companies in the field of manufacturing, partnering with global players such as Johnson & Johnson, Pfizer, iNova, Blackmores, and others for various drugs and other consumer health products.
CEO Pyridam Farma, Lee Yan Gwan, said,
“Pyridam Farma is taking a big step today by acquiring Probiotec Limited, one of the best pharmaceutical companies in Australia. In line with Pyridam Farma’s ambition to become a global pharmaceutical player, we recognize the importance of innovation and research (research & development). This acquisition will provide access to cutting-edge technology and also the opportunity to partner with global pharmaceutical players, which will ultimately benefit the pharmaceutical industry in Indonesia.”
